
Hypoallergenic formula withLactobacillus rhamnosus GGfor babies with colic: A pilot study of recruitment, retention, and fecal biomarkers
Author(s) -
Nicole Y. Fatheree,
Yuying Liu,
Michael J. Ferris,
Melissa Van Arsdall,
Valarie McMurtry,
Marcela Zozaya,
Chunyan Cai,
Mohammad H. Rahbar,
Manouchehr Hessabi,
Ta Vu,
Christine Wong,
Juleen Min,
Dat Q. Tran,
Fernando A. Navarro,
Wallace A. Gleason,
Sara González,
J. Marc Rhoads
Publication year - 2016
Publication title -
world journal of gastrointestinal pathophysiology
Language(s) - English
Resource type - Journals
ISSN - 2150-5330
DOI - 10.4291/wjgp.v7.i1.160
Subject(s) - medicine , lactobacillus rhamnosus , calprotectin , crying , infantile colic , feces , probiotic , placebo , gastroenterology , randomized controlled trial , population , hypoallergenic , lactobacillus reuteri , lactobacillus , significant difference , immunology , allergy , microbiology and biotechnology , food science , alternative medicine , psychiatry , bacteria , allergen , chemistry , environmental health , pathology , fermentation , genetics , biology , disease , inflammatory bowel disease
To investigate recruitment, retention, and estimates for effects of formula supplementation with Lactobacillus rhamnosus GG (LGG) on inflammatory biomarkers and fecal microbial community in infants with colic.